| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4935255 | Seizure | 2017 | 8 Pages |
Abstract
Perampanel was fairly effective in a heterogeneous group of 96 children and adolescents with very refractory epilepsy. The rate of adverse events leading to discontinuation was considerable in this group.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
N. Swiderska, H.J. Tan, A. Rajai, A. Silwal, A. Desurkar, T. Martland,